You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DGX Exercise Disclosure
Doherty Catherine T. · SEC Form 4 · Filed Nov 5, 2026
Exercise
Calculated transaction value
$2.69M
Doherty Catherine T. Executive Vice President
DGX
Transaction date
Nov 3, 2026
Public filing date
Nov 5, 2026
Filing lag
Filed 2 days later
DGX daily price context
Close on/before transaction
$247.06
Nov 3, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualifed Stock Option (right to buy) on Common Stock
- Quantity / price
- 22,105 shares @ $121.81
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001022079-26-000122
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$10.87M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Quest Diagnostics Inc DGX | Exercise | Nov 3, 2026 | $2.69M |
| Quest Diagnostics Inc DGX | Sale | Nov 3, 2026 | $730.35K |
| Quest Diagnostics Inc DGX | Award | Nov 3, 2026 | $0 |
| Quest Diagnostics Inc DGX | Sale | Nov 3, 2026 | $749.21K |
| Quest Diagnostics Inc DGX | Sale | Nov 3, 2026 | $585.69K |
| Quest Diagnostics Inc DGX Current | Exercise | Nov 3, 2026 | $2.69M |
| Quest Diagnostics Inc DGX | Sale | Nov 3, 2026 | $284.28K |
| Quest Diagnostics Inc DGX | Sale | Nov 3, 2026 | $937.14K |
| Quest Diagnostics Inc DGX | Sale | Nov 3, 2026 | $1.48M |
| Quest Diagnostics Inc DGX | Sale | Nov 3, 2026 | $720.65K |